Obalon To Present at Two Upcoming Institutional Investor Conferences

SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a?weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only?FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss,?announces that Bill Plovanic, President and Chief Executive Officer, will present corporate overviews at the following investor conferences:

Obalon To Present at Two Upcoming Institutional Investor Conferences

SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a?weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only?FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss,?announces that Bill Plovanic, President and Chief Executive Officer, will present corporate overviews at the following investor conferences: